Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × regorafenib × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 29 Carcinoma, Hepatocellular 12 Glioblastoma 5 Colonic Neoplasms 5 Sarcoma, Ewing 3 Rectal Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 31 Doxorubicin 20 pembrolizumab 19 fludarabine 18 Nivolumab 18 fludarabine phosphate 16 Vinblastine 16 Dacarbazine 16 Brentuximab Vedotin 16 Whole-Body Irradiation 15 Mycophenolic Acid 15 Etoposide 13 Melphalan 12 Filgrastim 11 Tacrolimus 10 Gemcitabine 10 Bleomycin 9 Rituximab 8 Radiotherapy 8 Granulocyte Colony-Stimulating Factor 8 Vincristine 7 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 pegfilgrastim 6 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Bendamustine Hydrochloride 6 Thiotepa 5 Specimen Handling 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡